Breathe people.
First Ryoncil sales at the end of the last quarter.
This quarters sales will be very good and surprise to the upside imho.
Next quarter sales will be outstanding.
We’re delivering an approved product that will be in the enormous demand. The system to traverse to get it to as many people as possible is complex in the US as we all know.
Our journey has been arduous no doubt over the previous years but it will be very well worth it in the coming months.
AND then we have adult acute graft vs host, back pain and cardiac markets to work our magic with…
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$1.80 |
Change
-0.055(2.97%) |
Mkt cap ! $2.293B | |||
| Open | High | Low | Value | Volume |
| $1.84 | $1.86 | $1.77 | $7.241M | 4.018M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 25472 | $1.80 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.81 | 1500 | 1 |
View Market Depth
| Last trade - 16.10pm 13/06/2025 (20 minute delay) ? |
| MSB (ASX) Chart |